News2022-08-15T12:01:27+00:00

FEATURED NEWS

Annex 21 to Come into Effect on August 21st 2022.

The effective date of the new Annex is 21 Aug 2022 – 5 business days from now. Are you ready? There are a number of key requirements for a Manufacturing Import Authorisation (MIA) holder when importing medicinal products (human, IMP, veterinary) from outside the EU/EEA. While none of these are new requirements, there you may need to take action relating to your Quality System controls and records.

BREXIT – Impact, Challenges and Solutions for the Pharmaceutical Industry

August 9th, 2022|Categories: Events, Featured, General Events|

Our CEO Ann McGee will be speaking at the Pharma and Brexit Conference - hosted by PDA Ireland and PDA United Kingdom. The event will

The Commenting Process for new GDP-relevant Documents from FDA and USP has been extended.

July 27th, 2022|Categories: Featured, General News, Industry News|

FDA Proposed Rule "National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers" In February 2022, the FDA has

MHRA (GxP) Inspections during COVID19

October 12th, 2020|

The COVID19 pandemic presents an unprecedented challenge to healthcare, the pharmaceutical industry’s supply chain and personnel movement. MHRA understands the impact of its work

LET US HELP YOU DELIVER YOUR PRODUCTS TO MARKET

Interested in our services or still have a question?

Go to Top